M. Peter Marinkovich, MD

Articles by M. Peter Marinkovich, MD

M. Peter Marinkovich, MD, on Bringing RDEB Treatment to the Local Level With B-VEC

April 20th 2024

The associate professor of dermatology at Stanford University discussed how the May 2023 approval of B-VEC may shift the treatment field for RDEB.

M. Peter Marinkovich, MD, on Increased Accessibility With Topical B-VEC DEB Gene Therapy

ByM. Peter Marinkovich, MD

February 6th 2024

The associate professor of dermatology at Stanford University discussed the potential impact of Vyjuvek’s approval in the derm field.

M. Peter Marinkovich, MD, on Developing B-VEC, First Approved Derm Gene Therapy

ByM. Peter Marinkovich, MD

December 7th 2023

The associate professor of dermatology at Stanford University discussed his experiences investigating and helping to develop Vyjuvek, approved for treating DEB.

M. Peter Marinkovich, MD

Articles by M. Peter Marinkovich, MD

M. Peter Marinkovich, MD, on Bringing RDEB Treatment to the Local Level With B-VEC

M. Peter Marinkovich, MD, on Increased Accessibility With Topical B-VEC DEB Gene Therapy

M. Peter Marinkovich, MD, on Developing B-VEC, First Approved Derm Gene Therapy

Latest Updated Articles

Trending on CGTlive®

Sarepta Therapeutics’ Limb-Girdle Muscular Dystrophy Gene Therapy SRP-9003 Produces “Robust Expression” of β-SG in Phase 3 Trial